NASDAQ
Cyclacel Pharmaceuticals, Inc. (CYCC) has a free cash flow growth of 96.92% as of Friday, May 29, 2026. This represents a 99.90% decrease compared to its 12-month average of 101747.21%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.